| Coronary artery disease: revascularization strategies for patients with CAD and diabetes. | |
| | |
MedLine Citation:
|
PMID: 20577296 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
CABG surgery has been considered the optimal revascularization strategy for patients with diabetes mellitus who have lexft main and/or multivessel coronary artery disease. The results of a new analysis of data from the SYNTAX trial challenge this conventional wisdom and highlight additional coronary revascularization options to physicians and patients. |
| | |
Authors:
|
G Robert Myers; William S Weintraub |
Related Documents
:
|
12678196 - Disease of proximal part of vertebral artery in patients with coronary artery disease. 8800986 - High dose dipyridamole as a pharmacological stress test during cardiac catheterisation ... 1681216 - Antithrombin iii and arterial disease. 15118986 - The relationship of anger expression and alexithymia with coronary artery stenosis in p... 10147176 - Characterization of a polyepoxy compound fixed porcine heart valve bioprosthesis. 18230956 - Arterial elasticity in cardiovascular disease: focus on hypertension, metabolic syndrom... |
Publication Detail:
|
Type: News |
Journal Detail:
|
Title: Nature reviews. Cardiology Volume: 7 ISSN: 1759-5010 ISO Abbreviation: Nat Rev Cardiol Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-06-25 Completed Date: 2010-11-22 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101500075 Medline TA: Nat Rev Cardiol Country: England |
Other Details:
|
Languages: eng Pagination: 364-6 Citation Subset: IM |
Affiliation:
|
Section of Cardiology, Room 2E99, Christiana Hospital, 4755 Ogletown-Stanton Road, Newark, DE 19718, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Balloon, Coronary
/
adverse effects,
instrumentation,
mortality Coronary Artery Bypass* / adverse effects, mortality Coronary Artery Disease / complications, mortality, therapy* Diabetes Mellitus, Type 2 / complications*, mortality Drug-Eluting Stents Evidence-Based Medicine Humans Patient Selection Randomized Controlled Trials as Topic Risk Assessment Risk Factors Treatment Outcome |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Interventional cardiology: does stent overlap make a difference to clinical outcome?
Next Document: Diabetes: making sense of the rosiglitazone controversy.